Veracyte | VCYT - المدينين التجاريين





المدينين التجاريين تغيير تاريخ
Agenus USD 22.44M 1.14M 2025-12
Agilent USD 1.5B 23M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Bruker USD 542.7M 2.2M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Illumina USD 738M 116M 2026-03
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Laboratory Of America USD 2.45B 189.8M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Siemens EUR 28.1B 1.3B 2026-03
Sonic Healthcare AUD 1.39B 23.76M 2024-12
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Veracyte USD 50.11M 5.45M 2026-03
Waters USD 1.76B 930.16M 2026-03